Cargando…
Clinical Genotyping of Non–Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes()
Detection of somatic mutations in non–small cell lung cancers (NSCLCs), especially adenocarcinomas, is important for directing patient care when targeted therapy is available. Here, we present our experience with genotyping NSCLC using the Ion Torrent Personal Genome Machine (PGM) and the AmpliSeq C...
Autores principales: | Tafe, Laura J., Pierce, Kirsten J., Peterson, Jason D., de Abreu, Francine, Memoli, Vincent A., Black, Candice C., Pettus, Jason R., Marotti, Jonathan D., Gutmann, Edward J., Liu, Xiaoying, Shirai, Keisuke, Dragnev, Konstantin H., Amos, Christopher I., Tsongalis, Gregory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031899/ https://www.ncbi.nlm.nih.gov/pubmed/27659017 http://dx.doi.org/10.1016/j.neo.2016.07.010 |
Ejemplares similares
-
Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor Board
por: Bernhardt, Erica B., et al.
Publicado: (2020) -
Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images
por: Tomita, Naofumi, et al.
Publicado: (2022) -
Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge
por: Al-Turkmani, M. Rabie, et al.
Publicado: (2020) -
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non–Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing
por: Shajani-Yi, Zahra, et al.
Publicado: (2018) -
Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors
por: Afzal, Muhammad Z, et al.
Publicado: (2019)